Core One acquires GMP Drug to bolster psychedelics production

word M and A made with wood building blocks, concept


Core One Labs (OTCQB:CLABF) acquired GMP Drug in a deal worth C$2.8M common stock plus bonus shares to pave the way to become a full-cycle psychedelics supply chain solution provider.

Privately held GMP Drug operates through a Good Manufacturing

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!